Studies do not link heart risk to bone drugs: FDA (Reuters)

Reuters - A review of clinical trial data from four drugmakers shows no overall risk of heart problems in patients taking drugs to treat osteoporosis, the U.S. Food and Drug Administration said on Wednesday. Read more...